Follow
Laura Romero Pérez
Laura Romero Pérez
PhD at German Cancer Research Center (DKFZ) - Heidelberg, Germany
Verified email at dkfz-heidelberg.de
Title
Cited by
Cited by
Year
Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity
K Vriens, S Christen, S Parik, D Broekaert, K Yoshinaga, A Talebi, ...
Nature 566 (7744), 403-406, 2019
2672019
Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma
MÁ Castilla, G Moreno‐Bueno, L Romero‐Pérez, KV De Vijver, ...
The Journal of pathology 223 (1), 72-80, 2011
2572011
Sarcoma classification by DNA methylation profiling
C Koelsche, D Schrimpf, D Stichel, M Sill, F Sahm, DE Reuss, M Blattner, ...
Nature communications 12 (1), 498, 2021
1642021
MicroRNA-200 family modulation in distinct breast cancer phenotypes
MÁ Castilla, J Díaz-Martín, D Sarrió, L Romero-Pérez, MÁ López-García, ...
PloS one 7 (10), e47709, 2012
1122012
ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma
L Romero-Pérez, MÁ López-García, J Díaz-Martín, M Biscuola, ...
Modern Pathology 26 (11), 1514-1524, 2013
762013
Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer
J Diaz-Martin, MÁ López-García, L Romero-Perez, MR Atienza-Amores, ...
Endocrine-related cancer 22 (3), 443-454, 2015
682015
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer
MÁ Castilla, MÁ López-García, MR Atienza, JM Rosa-Rosa, J Díaz-Martín, ...
Endocrine-related cancer 21 (4), 587-599, 2014
542014
Improving the management of Inherited Retinal Dystrophies by targeted sequencing of a population-specific gene panel
N Bravo-Gil, C Méndez-Vidal, L Romero-Pérez, M González-del Pozo, ...
Scientific reports 6 (1), 1-10, 2016
532016
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
J Musa, F Cidre-Aranaz, MM Aynaud, MF Orth, MML Knott, O Mirabeau, ...
Nature communications 10 (1), 4128, 2019
492019
DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1NFATc2 fusion from Ewing sarcoma
C Koelsche, M Kriegsmann, FKF Kommoss, D Stichel, K Kriegsmann, ...
Journal of cancer research and clinical oncology 145, 1273-1281, 2019
482019
STAG mutations in cancer
L Romero-Pérez, D Surdez, E Brunet, O Delattre, TGP Grünewald
Trends in cancer 5 (8), 506-520, 2019
382019
Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis
L Romero-Pérez, MÁ Castilla, MÁ López-García, J Díaz-Martín, ...
Human pathology 44 (2), 244-254, 2013
372013
A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas
MF Orth, VL Buecklein, E Kampmann, M Subklewe, E Noessner, ...
Cancer Immunology, Immunotherapy 69, 1353-1362, 2020
322020
Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
A Marchetto, S Ohmura, MF Orth, MML Knott, MV Colombo, C Arrigoni, ...
Nature Communications 11 (1), 2423, 2020
312020
Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma
Clinical Cancer Research, 2018
31*2018
DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics
FKF Kommoss, D Stichel, D Schrimpf, M Kriegsmann, B Tessier-Cloutier, ...
Journal of cancer research and clinical oncology 146, 97-104, 2020
292020
Oncogene alterations in endometrial carcinosarcomas
M Biscuola, K Van de Vijver, MÁ Castilla, L Romero-Pérez, ...
Human pathology 44 (5), 852-859, 2013
282013
A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer
L Romero-Pérez, P Garcia-Sanz, A Mota, S Leskelä, ...
Modern Pathology 28 (11), 1492-1503, 2015
262015
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma
M Dallmayer, J Li, S Ohmura, R Alba Rubio, MC Baldauf, TLB Hölting, ...
Cell death & disease 10 (2), 116, 2019
192019
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients
G Sannino, A Marchetto, A Ranft, S Jabar, C Zacherl, R Alba-Rubio, ...
EBioMedicine 47, 156-162, 2019
182019
The system can't perform the operation now. Try again later.
Articles 1–20